Shuting Han Profile
Shuting Han

@ShutingHan2

Followers
70
Following
83
Statuses
21

Gastrointestinal Medical oncologist @ National Cancer Center Singapore; NMRC research training fellow; immuno-oncology enthusiast

Joined December 2021
Don't wanna be here? Send us removal request.
@ShutingHan2
Shuting Han
21 days
RT @sundar__raghav: At #ascogi 2025. So excited to listen to the Keynote by @PamelaKunzMD on inclusive medicine and science. Such an apt ta…
0
6
0
@ShutingHan2
Shuting Han
22 days
Very proud of @tohhc John Chia Chee Kian and many others (across 11 countries and 66 sites) for bringing this trial to completion after >15 years of hard work and perseverance! A trial started in national cancer centre singapore 🇸🇬 just happy to be part of the story 🥳
@DrGopalIyer
Gopal Iyer
23 days
Aspirin after completion of standard adjuvant therapy for colorectal cancer (ASCOLT): an international, multicentre, phase 3, randomised, double-blind, placebo-controlled trial - The Lancet Gastroenterology & Hepatology Amazing work led by my colleagues!!
1
0
4
@ShutingHan2
Shuting Han
29 days
RT @LancetGastroHep: New research - Aspirin after completion of standard adjuvant therapy for colorectal cancer (ASCOLT): an international,…
0
6
0
@ShutingHan2
Shuting Han
2 months
RT @KaiKeenShiu: Fantastic to meet exciting generation of clinical trialists-scientists + make new friends with 🌎🌍🌏 experts #ESMOASIA24 @my
0
7
0
@ShutingHan2
Shuting Han
6 months
RT @KaiKeenShiu: Arrived in #Singapore @apgcs_summit to give an update on IO for MSI-H CRC and some hope for patients living with MSS CRC t…
0
6
0
@ShutingHan2
Shuting Han
1 year
RT @EvelynWongYT: Fact, #gioncologists are cool. A great honour to be part of the global #GI #oncology community! Truly appreciative of our…
0
8
0
@ShutingHan2
Shuting Han
1 year
RT @EvelynWongYT: ⚡️Truly an excellent discussion by @LizzySmyth1 @#ESMO23. 💥 KEYNOTE 585 & MATTERHORN - adding immunotherapy as neoadjuva…
0
4
0
@ShutingHan2
Shuting Han
1 year
RT @sundar__raghav: Grateful for the opportunity to discuss important data at #ESMO2023 on the rapidly growing role of immunotherapy in gas…
0
6
0
@ShutingHan2
Shuting Han
2 years
RT @apgcs_summit: The APGCS 2023 committee members welcome you all to attend the 10th Asia-Pacific Gastroenterology Cancer Summit happening…
0
1
0
@ShutingHan2
Shuting Han
2 years
RT @FrontGenetics: New Research: The distinct clinical trajectory, metastatic sites, and immunobiology of microsatellite-instability-high c…
0
2
0
@ShutingHan2
Shuting Han
2 years
RT @apgcs_summit: Prof. Toh Han Chong, APGCS Committee and Deputy Director, National Cancer Centre, Singapore, welcoming speech during the…
0
2
0
@ShutingHan2
Shuting Han
2 years
RT @EvelynWongYT: #happeningnow 1st SingHealth Peritoneal Surface Oncology Conference in 🇸🇬!. Congrats to @JohnnyOngCA @Jolenewongsm @ChiaC
0
1
0
@ShutingHan2
Shuting Han
3 years
RT @AvrahamCooperMD: What it looks like when a T cell DESTROYS a cancer cell 🤯 #MedTwitter
0
341
0
@ShutingHan2
Shuting Han
3 years
RT @iaintan_mdphd: Delighted to work with @shyam_lab, @SabineTejpar, Joanito & many talented colleagues on our paper, using insights from s…
0
35
0
@ShutingHan2
Shuting Han
3 years
RT @OncBrothers: #ASCO22 #PlenarySession summary 1. #DESTINYBreast04: TDXd in low HER2 mBC 2. #PARADIGM: Pan + mFOLFOX6 vs Bev + mFOLFOX6…
0
138
0
@ShutingHan2
Shuting Han
3 years
RT @AndreaCercek: Very proud of our study published in @NEJM. 100% clinical complete response with dostarlimab alone in mismatch repair-def…
0
1K
0
@ShutingHan2
Shuting Han
3 years
RT @EvelynWongYT: 💥The Voices of AYAO: 💥 A micro-documentary. Over the last year, my team and I visited 4 young adults across Singapore to…
0
2
0
@ShutingHan2
Shuting Han
3 years
@BMJ_Open Better late than never! What started as a discussion with @val_yang during the pandemic came to fruition — early but largest dataset on cancer and Covid-19
2
1
2